Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06711237Not ApplicableCompleted

Resin-Cement Type Influence on Cement Remnants in Implant-Supported Restorations

Role: lead

NCT06708247Not ApplicableCompleted

Reconstructive Therapy for Peri-implantitis Using Tuberosity Bone with or Without Electrolytic Cleaning: a Randomized Clinical Trial

Role: lead

NCT04737525Not ApplicableActive Not Recruiting

Connective Tissue Graft Versus a Porcine-derived Membrane (Mucoderm) After Immediate Placement

Role: lead

NCT04653025Not ApplicableActive Not Recruiting

Immedaite vs Early Implant Placement in Aesthetic Area

Role: lead

All 4 trials loaded